6
M. Mansueto et al. / Tetrahedron xxx (2014) 1e7
(w), 1712 (w), 1466 (w), 1366 (w), 1171 (w), 1058 (w), 905 (s), 728
(vs), 649 (m) cmꢁ1; MS(EI): m/z (%): 330 (21) [Mþ], 299 (12)
[MþꢁCH3O], 285 (100) [MþꢁC2H5O], 97 (6), 83 (7), 57 (8), 43 (5);
HRMS (ESI): m/z calculated for C20H42OSþ: 330.2956 [Mþ]; found:
330.2958.
30H, CH2), 1.51e1.62 (m, 2H, SCH2CH2), 2.52e2.60 (m, 2H, SCH2),
2.94e3.03 (m, 2H, SCH2CH2Im), 4.01 (s, 3H, ImCH3), 4.41e4.49 (m,
2H, CH2Im), 7.23e7.25 (m,1H, Im), 7.37e7.39 (m,1H, Im), 9.42e9.44
(m,1H, NCHN) ppm; 13C NMR (125 MHz, CDCl3, TMS):
d
¼14.1 (CH3),
22.7, 28.7, 29.22, 29.37, 29.43, 29.53, 29.62, 29.67, 29.71, 31.9 (CH2),
32.15, 32.19 (CH2), 36.6 (ImCH3), 49.4 (ImCH2), 122.49, 122.80 (Im),
4.5. General procedure for the synthesis of bromides 5aef
137.9 (NCHN) ppm; FTIR (ATR):
n
e¼3152 (w), 3115 (w), 2957 (w),
2918 (vs), 2850 (s), 2361 (w), 2253 (w), 1667 (w), 1576 (W), 1468
(w), 1379 (w), 1337 (w), 1256 (vs), 1225 (m), 1162 (s), 1031 (s), 908
(m), 735 (s), 639 (s), 621 (w), 574 (w) cmꢁ1; MS (ESI): m/z: 395
[Mþ], 335, 313 [MþꢁC4H6N2]; 149 [Mꢁ]; HRMS (ESI): m/z calculated
for C24H47N2Sþ: 395.3454 [Mþ]; found: 395.3434; calculated for
CF3O3Sꢁ: 148.9515 [Mꢁ]; found: 148.9534; DSC: Cr 54 ꢀC
[24.9 kJ molꢁ1] SmA 149 ꢀC [0.7 kJ molꢁ1] I.
The corresponding alcohol 4aef (0.91 mmol) and PPh3 (0.32 g,
1.23 mmol) were dissolved in abs. CH2Cl2 (10 mL) and CBr4 (0.41 g,
1.23 mmol) was added. The reaction mixture was stirred overnight
at room temperature. The solvent was removed under reduced
pressure and the crude product was purified through column
chromatography (hexanes/EtOAc 40:1; Rf¼0.7) to yield 5aef.15
4.5.1. (2-Bromoethyl)(octadecyl)sulfane 5f. Colourless solid (0.25 g,
4.7.2. 1-Methyl-3-(2-(octadecylthio)ethyl)-1H-imidazol-3-ium tetra-
0.65 mmol, 71%). 1H NMR (300 MHz, CDCl3, TMS):
d¼0.88 (t,
fluoroborate 6(C18)BF4. Colourless solid (13 mg, 0.02 mmol, 87%).
J¼6.8 Hz, 3H, CH3), 1.20e1.42 (m, 30H, CH2), 1.52e1.65 (m, 2H,
SCH2CH2), 2.51e2.59 (m, 2H, SCH2), 2.89e2.99 (m, 2H, SCH2CH2Br),
3.44e3.52 (m, 2H, CH2Br) ppm; 13C NMR (75 MHz, CDCl3, TMS):
1H NMR (500 MHz, CDCl3, TMS):
d
¼0.88 (t, J¼6.9 Hz, 3H, CH3),
1.18e1.41 (m, 30H, CH2),1.52e1.62 (m, 2H, SCH2CH2), 2.53e2.62 (m,
2H, SCH2), 2.95e3.05 (m, 2H, SCH2CH2Im), 4.02 (s, 3H, ImCH3),
4.45e4.53 (m, 2H, CH2Im), 7.22e7.25 (m, 1H, Im), 7.38e7.41 (m, 1H,
Im), 9.64e9.69 (m, 1H, NCHN) ppm; 13C NMR (125 MHz, CDCl3,
d
¼14.1 (CH3), 22.7, 28.8, 29.20, 29.37, 29.51, 29.59, 29.65, 29.67,
29.71, 29.79, 30.6, 31.9 (CH2), 32.4 (CH2), 34.2 (CH2Br) ppm; FTIR
(ATR):
n
e¼2921 (vs), 2951 (s), 2360 (w), 1739 (w),1466 (w),1189 (w),
TMS):
d
¼14.1 (CH3), 22.7, 28.8, 29.24, 29.37, 29.45, 29.54, 29.63,
721 (w), 613 (w) cmꢁ1; MS(EI): m/z (%): 392 (7) [Mþ], 313 (26), 286
(18), 285 (100), 97 (5), 69 (7), 57 (9), 43 (9); HRMS (EI): m/z cal-
culated for C20H41BrSþ: 392.2112 [Mþ]; found: 392.2112.
29.67, 29.68, 29.71, 31.9 (CH2), 32.23, 32.26 (CH2), 36.7 (ImCH3),
49.5 (ImCH2), 122.47, 122.74 (Im), 137.8 (NCHN) ppm; FTIR (ATR):
n
e¼3161 (w), 2958 (w), 2923 (m), 2852 (m), 2364 (w),1575 (w),1467
(w), 1379 (w), 1261 (w), 1171 (w), 1057 (m), 907 (s), 731 (vs), 646
4.6. General procedure for preparation of imidazolium bro-
mides 6(Cn)Br
(w), 622 (w) cmꢁ1 MS (ESI): m/z: 395 [Mþ], 335, 313
;
[MþꢁC4H6N2]; 87 [Mꢁ]; HRMS (ESI): m/z calculated for
C
24H47N2Sþ: 395.3454 [Mþ]; found: 395.3434; calculated for BF-4:
The corresponding bromide 5aef (0.15 mmol) and 1-
87.0024 [Mꢁ]; found: 87.0027; DSC: Cr 64 ꢀC [27.9 kJ molꢁ1]; de-
composition upon reaching the clearing temperature.
methylimidazole (0.12 mL, 12 mg, 0.15 mmol) were given in a mi-
crowave vial and irradiated in a microwave for 8 h at 140 ꢀC. The
crude product was recrystallized from EtOAc to afford the imida-
zolium bromides 6(Cn)Br.
Acknowledgements
€
Generous financial support by the Ministerium fur Wissen-
€
4.6.1. 1-Methyl-3-(2-(octadecylthio)ethyl)-1H-imidazol-3-ium bro-
schaft, Forschung und Kunst des Landes Baden-Wurttemberg, the
mide 6(C18)Br. Colourless solid (64 mg, 0.13 mmol, 91%). 1H NMR
Bundesministerium fur Bildung und Forschung (shared in-
€
(300 MHz, CDCl3, TMS):
d
¼0.88 (t, J¼6.7 Hz, 3H, CH3), 1.21e1.41 (m,
strumentation grant #01 RI 05177) and the Fonds der Chemischen
Industrie is gratefully acknowledged. We would like to thank
Christoph Schneck for the TGA experiments.
30H, CH2), 1.51e1.63 (m, 2H, SCH2CH2), 2.55e2.64 (m, 2H, SCH2),
3.01e3.09 (m, 2H, SCH2CH2Im), 4.09 (s, 3H, ImCH3), 4.59e4.66 (m,
2H, CH2Im), 7.22e7.24 (m, 1H, Im), 7.41e7.43 (m, 1H, Im), 10.74 (s,
1H, NCHN) ppm; 13C NMR (75 MHz, CDCl3, TMS):
d¼14.1 (CH3),
Supplementary data
22.7, 28.7, 29.24, 29.37, 29.46, 29.53, 29.62, 29.67, 31.9 (CH2), 32.39,
32.45 (CH2), 36.6 (ImCH3), 49.5 (ImCH2), 122.43 (Im), 138.6 (NCHN)
Further experimental results and supplementary figures. Sup-
plementary data related to this article can be found at http://
ppm; FTIR (ATR):
n
e¼3038 (w), 2953 (w), 2918 (vs), 2847 (s), 2360
(w), 1557 (w), 1466 (m), 1310 (w), 1217 (w), 1171 (m), 908 (w), 760
(w), 736 (m), 722 (m), 641 (w), 621 (w) cmꢁ1; MS (ESI): m/z: 395
[Mþ], 313 [MþꢁC4H6N2]; HRMS (ESI): m/z calculated for
References and notes
C
24H47N2Sþ: 395.2454 [Mþ]; found: 395.3469; mp: 41 ꢀC; de-
composition upon reaching the clearing temperature.
€
4.7. General procedure for the anion exchange
The respective imidazolium bromide 6(Cn)Br (0.13) was dis-
solved in MeCN (10 mL), the corresponding potassium salt
(0.14 mmol) was added and stirred under reflux for 1 h. After
cooling to room temperature the solvent was removed under re-
duced pressure, the residue dissolved in CH2Cl2 (10 mL) and fil-
tered. The solvent was removed under reduced pressure to obtain
the corresponding imidazolium triflates 6(Cn)OTf or tetra-
fluoroborate 6(C18)BF4.
ꢁ
ꢁ
ꢁ
4.7.1. 1-Methyl-3-(2-(octadecylthio)ethyl)-1H-imidazol-3-ium
flate 6(C18)OTf. Colourless solid (13 mg, 0.02 mmol, 87%). 1H NMR
(500 MHz, CDCl3, TMS):
¼0.88 (t, J¼6.9 Hz, 3H, CH3), 1.21e1.41 (m,
tri-
d